dihydrotestosterone has been researched along with Bone Cancer in 15 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (26.67) | 18.7374 |
1990's | 4 (26.67) | 18.2507 |
2000's | 6 (40.00) | 29.6817 |
2010's | 1 (6.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fox, JJ; Goldman, DA; Gonen, M; Hricak, H; Kuk, D; Larson, SM; Morris, MJ; Scher, HI; Vargas, HA; Wassberg, C; Wibmer, A | 1 |
Coleman, I; Corey, E; Koreckij, TD; Montgomery, RB; Nelson, PS; Nguyen, H; Pitts, TE; Reading, CL; Trauger, RJ; Vessella, RL | 1 |
Bauman, DR; Lin, HK; Peehl, DM; Penning, TM; Rizner, TL; Steckelbroeck, S | 1 |
Akhurst, TA; Beattie, B; Bornmann, W; Dyke, J; Erdi, Y; Finn, RD; Gunther, I; Humm, JL; Larson, SM; McCarthy, T; Morris, M; Pentlow, K; Scher, H; Squire, O; Welch, M | 1 |
Akahira, J; Dohi, O; Hatori, M; Hosaka, M; Itoi, E; Miki, Y; Nagasaki, S; Ono, K; Sasano, H; Suzuki, T | 1 |
Boffa, GA; Cutuli, B; Dine, G; Facchini, T; Lesaunier, F | 1 |
Drago, JR; Harvey, HA; Lipton, A; Rohner, TJ; Samojlik, E; Santen, RJ; Veldhuis, JD; Worgul, TJ | 1 |
Barnard, J; Brass, AL; Patai, BL; Rukstalis, DB; Salvi, D | 1 |
Chang, C; Keenan, E; Orwoll, ES; Wiren, KM; Zhang, X | 1 |
Fidler, IJ; Greene, G; Killion, JJ; Pathak, S; Pettaway, CA; Ramirez, E; Wilson, MR | 1 |
Babkina, TV; Degtiar', VG; Kushlinskiĭ, NE; Solov'ev, IuN; Trapeznikov, NN | 1 |
Aliev, MD; Babkina, TV; Degtiar', VG; Kushlinskiĭ, NE; Solov'ev, IuN; Trapeznikov, NN | 1 |
Chang, SM; Chung, LW; Degeorges, A; Ozen, M; Pathak, S; Sikes, RA; Thalmann, GN; Wu, TT | 1 |
Chenu, C; Delmas, PD; Meunier, PJ; Saez, S; Valentin-Opran, A; Vicard, E | 1 |
Honetz, N; Neumann, E; Wurm, B | 1 |
1 trial(s) available for dihydrotestosterone and Bone Cancer
Article | Year |
---|---|
Tumor localization of 16beta-18F-fluoro-5alpha-dihydrotestosterone versus 18F-FDG in patients with progressive, metastatic prostate cancer.
Topics: Aged; Bone Neoplasms; Dihydrotestosterone; Fluorodeoxyglucose F18; Humans; Male; Metabolic Clearance Rate; Middle Aged; Prostatic Neoplasms; Radiopharmaceuticals; Receptors, Androgen; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution; Tomography, Emission-Computed; Whole-Body Counting | 2004 |
14 other study(ies) available for dihydrotestosterone and Bone Cancer
Article | Year |
---|---|
Bone metastases in castration-resistant prostate cancer: associations between morphologic CT patterns, glycolytic activity, and androgen receptor expression on PET and overall survival.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Cross-Sectional Studies; Diatrizoate; Diatrizoate Meglumine; Dihydrotestosterone; Fluorodeoxyglucose F18; Glycolysis; Humans; Male; Multimodal Imaging; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Receptors, Androgen; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed | 2014 |
HE3235 inhibits growth of castration-resistant prostate cancer.
Topics: Androstanols; Animals; Antineoplastic Agents; Bone Neoplasms; Castration; Dihydrotestosterone; Gene Expression; Humans; Immunohistochemistry; Male; Mice; Mice, Nude; Neoplasm Metastasis; Prostatic Neoplasms; Receptors, Androgen; Reverse Transcriptase Polymerase Chain Reaction; Testosterone; Xenograft Model Antitumor Assays | 2009 |
Human type 3 3alpha-hydroxysteroid dehydrogenase (aldo-keto reductase 1C2) and androgen metabolism in prostate cells.
Topics: 17-Hydroxysteroid Dehydrogenases; Adenocarcinoma; Androstane-3,17-diol; Animals; Bone Neoplasms; COS Cells; Dihydrotestosterone; Epithelial Cells; Gene Expression Regulation, Enzymologic; Humans; Hydroxysteroid Dehydrogenases; In Vitro Techniques; Isoenzymes; Male; Prostate; Prostatic Neoplasms; Testosterone; Tumor Cells, Cultured | 2003 |
Sex steroid receptors expression and hormone-induced cell proliferation in human osteosarcoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Case-Control Studies; Cell Line, Tumor; Cell Proliferation; Child; Child, Preschool; Dihydrotestosterone; Estradiol; Female; Gonadal Steroid Hormones; Humans; Immunohistochemistry; Male; Middle Aged; Osteosarcoma; Progesterone; Receptors, Androgen; Receptors, Estrogen; Receptors, Progesterone; Receptors, Steroid | 2008 |
[Polycythemia associated with breast cancer and bone metastases. Role of androgen therapy].
Topics: Bone Neoplasms; Breast Neoplasms; Carcinoma; Dihydrotestosterone; Female; Humans; Middle Aged; Polycythemia | 1984 |
Clinical and biochemical effect of aminoglutethimide in the treatment of advanced prostatic carcinoma.
Topics: Adenocarcinoma; Aged; Aminoglutethimide; Bone Neoplasms; Dihydrotestosterone; Drug Therapy, Combination; Humans; Hydrocortisone; Male; Middle Aged; Prostatic Neoplasms; Testosterone | 1983 |
Androgen up-regulates epidermal growth factor receptor expression and binding affinity in PC3 cell lines expressing the human androgen receptor.
Topics: Adenocarcinoma; Androgens; Animals; Bone Neoplasms; Cell Division; Dihydrotestosterone; Drug Synergism; Epidermal Growth Factor; ErbB Receptors; Gene Expression; Gene Expression Regulation, Neoplastic; Humans; Lymphatic Metastasis; Male; Mice; Neoplasms, Hormone-Dependent; Prostatic Neoplasms; Receptors, Androgen; Stimulation, Chemical; Transforming Growth Factor alpha; Tumor Cells, Cultured; Up-Regulation | 1995 |
Transcriptional up-regulation of the human androgen receptor by androgen in bone cells.
Topics: Bone Neoplasms; Chloramphenicol O-Acetyltransferase; Dexamethasone; Dihydrotestosterone; Estradiol; Genes, Reporter; Humans; Kinetics; Male; Osteoblasts; Osteosarcoma; Plasmids; Progesterone; Promoter Regions, Genetic; Prostatic Neoplasms; Receptors, Androgen; Recombinant Fusion Proteins; RNA, Messenger; Transcription, Genetic; Transfection; Tumor Cells, Cultured; Up-Regulation | 1997 |
Selection of highly metastatic variants of different human prostatic carcinomas using orthotopic implantation in nude mice.
Topics: Animals; Bone Neoplasms; Cell Division; Culture Media; Dihydrotestosterone; Genetic Variation; Humans; Karyotyping; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Metastasis; Neoplasm Transplantation; Orchiectomy; Prostate-Specific Antigen; Prostatic Neoplasms; Tumor Cells, Cultured | 1996 |
[Formation of 5alpha-dihydrotestosterone in human bone tumors of various histology].
Topics: Bone Neoplasms; Cholestenone 5 alpha-Reductase; Chondrosarcoma; Dihydrotestosterone; Giant Cell Tumors; Humans; Osteosarcoma; Oxidoreductases | 1999 |
[Androgen metabolism in malignant and benign bone tumors].
Topics: Adolescent; Adult; Androgens; Bone Neoplasms; Chondrosarcoma; Dihydrotestosterone; Female; Giant Cell Tumors; Humans; Male; Middle Aged; Osteosarcoma; Sarcoma, Ewing; Testosterone | 2000 |
LNCaP progression model of human prostate cancer: androgen-independence and osseous metastasis.
Topics: Animals; Blotting, Northern; Bone Neoplasms; Cell Line; Dihydrotestosterone; Disease Models, Animal; Gene Expression Regulation, Neoplastic; Gentian Violet; Histocytochemistry; Humans; Image Processing, Computer-Assisted; Immunoenzyme Techniques; Karyotyping; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Orchiectomy; Osteosarcoma; Prostate-Specific Antigen; Prostatic Neoplasms; RNA, Neoplasm; Specific Pathogen-Free Organisms; Tumor Cells, Cultured | 2000 |
Androgens increase osteoblast-stimulating activity of human breast cancer cells in vitro.
Topics: Androgens; Bone Neoplasms; Breast Neoplasms; Cell Line; Culture Media; Dihydrotestosterone; DNA; Dose-Response Relationship, Drug; Female; Growth Substances; Humans; Osteoblasts | 1986 |
[The behavior of erythropoietin in aregenerative disorders of erythropoiesis during therapy with anabolic steroids].
Topics: Agranulocytosis; Anemia, Aplastic; Anemia, Macrocytic; Bone Marrow Examination; Bone Neoplasms; Breast Neoplasms; Dihydrotestosterone; Erythropoiesis; Erythropoietin; Female; Hepatitis; Humans; Iron; Iron Radioisotopes; Male; Oxymetholone; Prednisolone; Sepsis; Transfusion Reaction | 1974 |